Fiorelli, S.; Porro, B.; Cosentino, N.; Di Minno, A.; Manega, C.M.; Fabbiocchi, F.; Niccoli, G.; Fracassi, F.; Barbieri, S.; Marenzi, G.;
et al. Activation of Nrf2/HO-1 Pathway and Human Atherosclerotic Plaque Vulnerability: An In Vitro and In Vivo Study. Cells 2019, 8, 356.
https://doi.org/10.3390/cells8040356
AMA Style
Fiorelli S, Porro B, Cosentino N, Di Minno A, Manega CM, Fabbiocchi F, Niccoli G, Fracassi F, Barbieri S, Marenzi G,
et al. Activation of Nrf2/HO-1 Pathway and Human Atherosclerotic Plaque Vulnerability: An In Vitro and In Vivo Study. Cells. 2019; 8(4):356.
https://doi.org/10.3390/cells8040356
Chicago/Turabian Style
Fiorelli, Susanna, Benedetta Porro, Nicola Cosentino, Alessandro Di Minno, Chiara Maria Manega, Franco Fabbiocchi, Giampaolo Niccoli, Francesco Fracassi, Simone Barbieri, Giancarlo Marenzi,
and et al. 2019. "Activation of Nrf2/HO-1 Pathway and Human Atherosclerotic Plaque Vulnerability: An In Vitro and In Vivo Study" Cells 8, no. 4: 356.
https://doi.org/10.3390/cells8040356
APA Style
Fiorelli, S., Porro, B., Cosentino, N., Di Minno, A., Manega, C. M., Fabbiocchi, F., Niccoli, G., Fracassi, F., Barbieri, S., Marenzi, G., Crea, F., Cavalca, V., Tremoli, E., & Eligini, S.
(2019). Activation of Nrf2/HO-1 Pathway and Human Atherosclerotic Plaque Vulnerability: An In Vitro and In Vivo Study. Cells, 8(4), 356.
https://doi.org/10.3390/cells8040356